Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04997902
Title Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Kura Oncology, Inc.
Indications

head and neck squamous cell carcinoma

Therapies

Alpelisib + Tipifarnib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Recruiting Duarte California 91010 United States Details
Lake Nona DDU (Florida Cancer Specialists) Recruiting Orlando Florida 32827 United States Details
Dana-Farber Cancer Institute (Head and Neck Cancer Treatment Center) Recruiting Boston Massachusetts 02215 United States Details
Washington University, School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
UPMC Hillman Cancer Center Recruiting Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field